David Joseph Iberri, MD
Internal Medicine · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 17
- 3 carriers
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
17 plans · 3 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Iberri’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
17 of 17 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A117947 · Current
Licensed to practise in California · since 2011 · expires 2028-09-30 · University of Vermont College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$202,956
Medicare paid this office $202,956 for 557 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 182 | $69,779 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $43,426 | $106 |
| Return visit (30+ min) | 190 | $25,767 | $109 |
| Long return visit (40+ min) | 66 | $17,232 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,542 | $155 |
See all 12 services
| Long return visit (40+ min) | 182 | $69,779 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $43,426 | $106 |
| Return visit (30+ min) | 190 | $25,767 | $109 |
| Long return visit (40+ min) | 66 | $17,232 | $129 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 59 | $10,542 | $155 |
| Hospital discharge day management, more than 30 minutes | 71 | $8,052 | $105 |
| New patient visit (60+ min) | 33 | $6,780 | $205 |
| Return visit (30+ min) | 57 | $5,514 | $81 |
| New patient visit (45+ min) | 31 | $4,680 | $151 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 222 | $4,479 | $15 |
| New patient visit (60+ min) | 19 | $3,103 | $163 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 77 | $1,618 | $15 |
Who their Medicare patients are
557 Original Medicare patients in 2024. Average age 75 · Under 65 7% · 85 and older 13% · Women 44% · Also on Medicaid 23% · Health risk score 2.36. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 70% · Chronic kidney disease 34% · Coronary heart disease 32% · Diabetes 28% · Cancer 25% · Atrial fibrillation 25% · Heart failure 24% · Depression 20% · COPD 14% · Dementia 10% · Stroke 9%.
The office billed $973,903, Medicare allowed $264,046 and paid $202,956; for 1,937 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 557 | 1,937 | 75 | 2.36 | $973,903 | $202,956 |
| 2023 | 528 | 1,472 | 75 | 2.38 | $829,159 | $160,606 |
| 2022 | 476 | 1,362 | 74 | 2.18 | $789,552 | $144,572 |
| 2021 | 472 | 1,292 | 74 | 2.33 | $768,207 | $154,474 |
| 2020 | 422 | 1,162 | 72 | 2.35 | $577,797 | $118,123 |
| 2019 | 464 | 1,400 | 72 | 2.51 | $361,622 | $139,018 |
| 2018 | 372 | 979 | 72 | 2.32 | $229,415 | $92,716 |
| 2017 | 474 | 1,413 | 72 | 2.29 | $443,114 | $134,377 |
| 2016 | 299 | 896 | 70 | 2.11 | $294,208 | $86,875 |
| 2015 | 79 | 194 | 72 | 2.01 | $70,127 | $20,745 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 156 | $51,967 | $127 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $44,433 | $108 |
| Return visit (30+ min) | 241 | $29,113 | $82 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 54 | $9,708 | $159 |
| Hospital discharge day management, more than 30 minutes | 74 | $9,065 | $107 |
| New patient visit (45+ min) | 56 | $6,873 | $123 |
| New patient visit (60+ min) | 36 | $6,051 | $168 |
| Short return visit (20+ min) | 29 | $1,406 | $48 |
2022: 8 services
| Long return visit (40+ min) | 168 | $51,624 | $124 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 65 | $30,928 | $93 |
| Return visit (30+ min) | 229 | $28,520 | $85 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 51 | $9,315 | $183 |
| New patient visit (60+ min) | 55 | $8,632 | $157 |
| Hospital discharge day management, more than 30 minutes | 54 | $5,586 | $98 |
| New patient visit (45+ min) | 44 | $4,603 | $105 |
| Short return visit (20+ min) | 28 | $1,556 | $54 |
2021: 9 services
| Long return visit (40+ min) | 201 | $73,561 | $143 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $23,960 | $95 |
| Return visit (30+ min) | 155 | $18,327 | $88 |
| New patient visit (60+ min) | 53 | $9,498 | $179 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $9,437 | $185 |
| New patient visit (45+ min) | 63 | $7,825 | $124 |
| Hospital discharge day management, more than 30 minutes | 57 | $6,004 | $100 |
| Short return visit (20+ min) | 31 | $1,978 | $58 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,536 | $102 |
2020: 13 services
| Long return visit (40+ min) | 135 | $37,466 | $108 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 66 | $28,425 | $97 |
| Return visit (30+ min) | 126 | $11,966 | $73 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 40 | $7,916 | $188 |
| New patient visit (60+ min) | 43 | $6,856 | $159 |
| Hospital discharge day management, more than 30 minutes | 60 | $6,727 | $102 |
| New patient visit (45+ min) | 57 | $6,661 | $117 |
| Long return visit (40+ min) | 30 | $3,878 | $111 |
| Return visit (30+ min) | 44 | $3,326 | $74 |
| New patient visit (45+ min) | 11 | $1,385 | $126 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $850 | $71 |
| New patient visit (30+ min) | 11 | $775 | $70 |
| Telehealth originating site facility fee | 16 | $341 | $21 |
2019: 7 services
| Long return visit (40+ min) | 192 | $44,844 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 107 | $44,052 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $12,203 | $182 |
| Hospital discharge day management, more than 30 minutes | 88 | $10,709 | $99 |
| Return visit (30+ min) | 112 | $9,803 | $67 |
| New patient visit (60+ min) | 60 | $8,861 | $148 |
| New patient visit (45+ min) | 54 | $6,253 | $116 |
2018: 9 services
| Long return visit (40+ min) | 139 | $29,512 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $21,685 | $92 |
| Return visit (30+ min) | 120 | $11,238 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 39 | $9,096 | $182 |
| Hospital discharge day management, more than 30 minutes | 58 | $7,801 | $98 |
| New patient visit (45+ min) | 58 | $6,225 | $107 |
| New patient visit (60+ min) | 27 | $3,920 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,634 | $65 |
| New patient visit (30+ min) | 17 | $1,105 | $65 |
2017: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 98 | $44,425 | $91 |
| Long return visit (40+ min) | 179 | $35,888 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $14,542 | $180 |
| Return visit (30+ min) | 153 | $12,254 | $59 |
| Hospital discharge day management, more than 30 minutes | 82 | $10,655 | $97 |
| New patient visit (60+ min) | 56 | $8,076 | $144 |
| New patient visit (45+ min) | 47 | $5,140 | $109 |
| Short return visit (20+ min) | 12 | $411 | $34 |
2016: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $34,221 | $92 |
| Long return visit (40+ min) | 79 | $12,901 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $9,193 | $180 |
| Return visit (30+ min) | 77 | $9,020 | $69 |
| Hospital discharge day management, more than 30 minutes | 60 | $7,585 | $97 |
| New patient visit (60+ min) | 43 | $6,308 | $147 |
| New patient visit (45+ min) | 50 | $5,162 | $103 |
| Short return visit (20+ min) | 19 | $957 | $46 |
| New patient visit (30+ min) | 11 | $684 | $62 |
2015: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 23 | $7,092 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,354 | $181 |
| Hospital discharge day management, more than 30 minutes | 21 | $2,449 | $98 |
| New patient visit (60+ min) | 16 | $2,404 | $150 |
| Long return visit (40+ min) | 12 | $1,892 | $100 |
| Return visit (30+ min) | 16 | $1,195 | $70 |
Medicaid work
$8,848 in 2024
Medicaid paid $8,848 for 250 billed services this clinician did in 2024, up to 23 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 94 | $3,874 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 115 | $3,636 |
| Return visit (30+ min) | 25 | $1,302 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 16 | $36 |
| 2024 | 250 | 4 | 23 | $8,848 |
| 2023 | 520 | 5 | 17 | $18,629 |
| 2022 | 90 | 2 | 16 | $3,702 |
| 2021 | 324 | 4 | 19 | $13,942 |
| 2020 | 108 | 1 | 18 | $5,068 |
| 2019 | 162 | 2 | 21 | $7,728 |
| 2018 | 73 | 3 | 15 | $3,766 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 355 | $13,174 |
| Long return visit (40+ min) | 72 | $1,949 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 51 | $1,756 |
| Return visit (30+ min) | 29 | $1,082 |
| 1ST HOSP IP/OBS HIGH 75 | 13 | $669 |
2022
| Long return visit (40+ min) | 48 | $2,097 |
| Return visit (30+ min) | 42 | $1,605 |
2021
| Long return visit (40+ min) | 136 | $5,706 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 129 | $5,635 |
| Return visit (30+ min) | 47 | $1,923 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 12 | $679 |
2020
| Long return visit (40+ min) | 108 | $5,068 |
2019
| Long return visit (40+ min) | 150 | $7,085 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 12 | $643 |
2018
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 31 | $1,553 |
| Long return visit (40+ min) | 28 | $1,357 |
| 1ST HOSP IP/OBS HIGH 75 | 14 | $856 |
Drugs they prescribed that Part D paid
$629,909
Pharmacies billed $629,909 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
138 generic and fewer than 11 brand-name prescriptions · $629,909 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Entecavir | 12 | $2,951 | $246 |
| Acyclovir | 30 | $765 | $26 |
| Dexamethasone | 17 | $457 | $27 |
Year by year
| 2024 | 199 | 61 | None | None | $629,909 |
| 2023 | 176 | 53 | 7% (12) | None | $553,476 |
| 2022 | 220 | 64 | None | None | $947,102 |
| 2021 | 271 | 67 | None | 55% | $2,138,939 |
| 2020 | 265 | 61 | None | None | $1,562,383 |
| 2019 | 488 | 97 | None | None | $2,338,777 |
| 2018 | 410 | 68 | None | 47% | $1,778,236 |
| 2017 | 462 | 88 | None | 57% | $2,224,088 |
| 2016 | 154 | 31 | None | 39% | $322,673 |
| 2015 | 60 | 17 | None | None | $47,271 |
| 2014 | 15 | 12 | 73% (11) | None | $777 |
| 2013 | 16 | None | None | None | $624 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Acyclovir | 26 | $798 | $31 |
| Dexamethasone | 28 | $476 | $17 |
2022: 7 drugs
| Revlimid | 14 | $255,567 | $18,255 |
| Imbruvica | 15 | $218,958 | $14,597 |
| Eliquis | 18 | $21,221 | $1,179 |
| Acyclovir | 22 | $745 | $34 |
| Dexamethasone | 15 | $479 | $32 |
| Ondansetron | 12 | $355 | $30 |
| Hydroxyurea | 11 | $247 | $22 |
2021: 8 drugs
| Revlimid | 75 | $1,319,469 | $17,593 |
| Pomalyst | 15 | $303,801 | $20,253 |
| Imbruvica | 11 | $153,974 | $13,998 |
| Imatinib Mesylate | 13 | $52,313 | $4,024 |
| Eliquis | 26 | $29,436 | $1,132 |
| Acyclovir | 20 | $1,133 | $57 |
| Hydroxyurea | 16 | $607 | $38 |
| Dexamethasone | 15 | $554 | $37 |
2020: 7 drugs
| Revlimid | 64 | $1,013,376 | $15,834 |
| Imbruvica | 14 | $194,018 | $13,858 |
| Jakafi | 11 | $134,073 | $12,188 |
| Eliquis | 17 | $14,201 | $835 |
| Acyclovir | 40 | $1,036 | $26 |
| Hydroxyurea | 17 | $642 | $38 |
| Dexamethasone | 24 | $555 | $23 |
2019: 11 drugs
| Revlimid | 82 | $1,268,941 | $15,475 |
| Pomalyst | 26 | $458,950 | $17,652 |
| Imbruvica | 20 | $247,190 | $12,360 |
| Promacta | 12 | $90,420 | $7,535 |
| Eliquis | 31 | $17,800 | $574 |
| Xarelto | 12 | $8,069 | $672 |
| Enoxaparin | 14 | $4,409 | $315 |
| Acyclovir | 70 | $1,324 | $19 |
| Hydroxyurea | 23 | $669 | $29 |
| Dexamethasone | 21 | $527 | $25 |
| Sulfamethoxazole-Trimethoprim | 11 | $55 | $5 |
2018: 11 drugs
| Revlimid | 64 | $828,684 | $12,948 |
| Imbruvica | 33 | $384,650 | $11,656 |
| Imatinib Mesylate | 15 | $78,245 | $5,216 |
| Procrit | 12 | $44,100 | $3,675 |
| Eliquis | 29 | $14,572 | $502 |
| Xarelto | 19 | $9,099 | $479 |
| Anagrelide | 11 | $874 | $79 |
| Acyclovir | 44 | $745 | $17 |
| Hydroxyurea | 30 | $549 | $18 |
| Dexamethasone | 27 | $377 | $14 |
| Prednisone | 13 | $121 | $9 |
2017: 14 drugs
| Revlimid | 41 | $524,276 | $12,787 |
| Imbruvica | 45 | $456,424 | $10,143 |
| Ferriprox | 13 | $235,743 | $18,134 |
| Blincyto | 15 | $221,721 | $14,781 |
| Imatinib Mesylate | 18 | $155,274 | $8,626 |
| Promacta | 14 | $87,639 | $6,260 |
| Gleevec | 12 | $67,163 | $5,597 |
| Eliquis | 55 | $23,344 | $424 |
| Xarelto | 14 | $8,042 | $574 |
| Enoxaparin | 11 | $3,867 | $352 |
| Hydroxyurea | 24 | $491 | $20 |
| Acyclovir | 23 | $430 | $19 |
| Dexamethasone | 31 | $338 | $11 |
| Prednisone | 39 | $315 | $8 |
2016: 5 drugs
| Jakafi | 13 | $136,436 | $10,495 |
| Promacta | 11 | $57,745 | $5,250 |
| Eliquis | 19 | $6,941 | $365 |
| Acyclovir | 13 | $301 | $23 |
| Prednisone | 20 | $175 | $9 |
Professional record
- NPI
- 1821300625
- Licence
- CA A117947California A117947: Current · expires 2028-09-30
- Trained
- University of Vermont College of Medicine, 2010
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207RH0000X (207RH0000X); Medical oncology (207RX0202X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2010-07-08
- NPI last updated
- 2026-08-25
- NPI record certified
- 2026-08-25
This is when the NPI record was last certified, not a medical board exam.